miR-660–5p preserves CML LSCs by interacting with the 3′ UTR of endothelial PAS domain protein 1 (EPAS1), hence diminishing its role in modulating cellular responses to hypoxic conditions [157]. This evidence concerns the gene EPAS1 and chronic myelogenous leukemia, BCR-ABL1 positive.